Asset
Amphetamine sulfate
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00150579 | phase3 | completed | 2005-01-27 | 2005-06-14 | Shire | Efficacy and Safety of SPD465 in Adults With ADHD |
| NCT00202605 | phase2 | completed | 2005-09-29 | 2006-01-06 | Shire | Safety and Efficacy of SPD465 in Adults With ADHD |
| NCT00152035 | phase3 | completed | 2005-03-10 | 2006-11-07 | Shire | Safety of SPD465 in Treating Adults With ADHD. |
FDA applications (2)
| Application | Type | Applicant |
|---|---|---|
| NDA 021303 | NDA | TAKEDA PHARMACEUTICALS USA INC |
| NDA 022063 | NDA | TAKEDA PHARMACEUTICALS USA INC |
Marketed products (10)
- ADDERALL XR 10
- ADDERALL XR 15
- ADDERALL XR 20
- ADDERALL XR 25
- ADDERALL XR 30
- ADDERALL XR 5
- MYDAYIS
- MYDAYIS
- MYDAYIS
- MYDAYIS